Alcobra Finishes Follow-up Visits on Phase III Trial on MDX

Alcobra Ltd. (ADHD) recently announced that all scheduled follow-up visits have been completed for patients enrolled in the phase III trial on MDX.

from Content Keyword RSS http://ift.tt/1x8R4KQ http://ift.tt/eA8V8J

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s